Hydroxytyrosol
is an olive-derived phenolic compound of increasing
commercial interest due to its health-promoting properties. In this
study, a high-yield hydroxytyrosol-producing Saccharomyces
cerevisiae cell factory was established via a comprehensive
metabolic engineering scheme. First, de novo biosynthetic
pathway of hydroxytyrosol was constructed in yeast by gene screening
and overexpression of different phenol hydroxylases, among which paHD
(from Pseudomonas aeruginosa) displayed
the best catalytic performance. Next, hydroxytyrosol precursor supply
was enhanced via a multimodular engineering approach: elimination
of tyrosine feedback inhibition through genomic integration of aro4
K229L
and aro7
G141S
, construction of an aromatic aldehyde
synthase (AAS)-based tyrosine metabolic pathway, and redistribution
of metabolic flux between glycolytic pathway and pentose phosphate
pathway (PPP) by introducing the exogenous gene Bbxfpk
opt
. As a result, the titer of hydroxytyrosol
was improved by 6.88-fold. Finally, a glucose-responsive dynamic regulation
system based on GAL80 deletion was implemented, resulting
in the final hydroxytyrosol yields of 308.65 mg/L and 167.98 mg/g
cell mass, the highest known from de novo production
in S. cerevisiae to date.